P50 (NF-κB1) is an effector protein in the cytotoxic response to DNA methylation damage

Molecular Cell

Volumn 44, Issue 5, 2011, Pages 785-796

  Schmitt, Adam M ^a   Crawley, Clayton D ^a   Kang, Shijune ^a   Raleigh, David R ^a   Yu, Xiaohong ^a   Wahlstrom, Joshua S ^a   Voce, David J ^a   Darga, Thomas E ^a   Weichselbaum, Ralph R ^a   Yamini, Bakhtiar ^a  

^a UNIVERSITY OF CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

6 O METHYLGUANINE; CHECKPOINT KINASE 1; DNA; DNA BINDING PROTEIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; PROTEIN P50; TEMOZOLOMIDE;

ANIMAL CELL; APOPTOSIS; ARTICLE; ATTENUATION; CELL CYCLE S PHASE; CELL DEATH; CONTROLLED STUDY; CYTOTOXICITY; DNA BINDING; DNA DAMAGE; DNA METHYLATION; DRUG INHIBITION; EFFECTOR CELL; GENE EXPRESSION; GROWTH INHIBITION; MISMATCH REPAIR; NONHUMAN; PROTEIN ANALYSIS; PROTEIN INDUCTION; PROTEIN PHOSPHORYLATION; PROTEIN TARGETING; SIGNAL TRANSDUCTION;

ANIMALS; CELL DEATH; CELL LINE, TUMOR; DNA DAMAGE; DNA METHYLATION; HUMANS; MICE; NF-KAPPA B P50 SUBUNIT;

EID: 83455201681     PISSN: 10972765     EISSN: 10974164     Source Type: Journal    
DOI: 10.1016/j.molcel.2011.09.026     Document Type: Article

References (28)

1. Birbach A., Gold P., Binder B.R., Hofer E., de Martin R., Schmid J.A. Signaling molecules of the NF-kappa B pathway shuttle constitutively between cytoplasm and nucleus. J. Biol. Chem. 2002, 277:10842-10851.
2. Campbell K.J., Rocha S., Perkins N.D. Active repression of antiapoptotic gene expression by RelA(p65) NF-kappa B. Mol. Cell 2004, 13:853-865.
3. Campbell K.J., Witty J.M., Rocha S., Perkins N.D. Cisplatin mimics ARF tumor suppressor regulation of RelA (p65) nuclear factor-kappaB transactivation. Cancer Res. 2006, 66:929-935.
4. Carlotti F., Dower S.K., Qwarnstrom E.E. Dynamic shuttling of nuclear factor kappa B between the nucleus and cytoplasm as a consequence of inhibitor dissociation. J. Biol. Chem. 2000, 275:41028-41034.
5. Dolan M.E., Moschel R.C., Pegg A.E. Depletion of mammalian O6-alkylguanine-DNA alkyltransferase activity by O6-benzylguanine provides a means to evaluate the role of this protein in protection against carcinogenic and therapeutic alkylating agents. Proc. Natl. Acad. Sci. USA 1990, 87:5368-5372.
6. Fishel R. The selection for mismatch repair defects in hereditary nonpolyposis colorectal cancer: revising the mutator hypothesis. Cancer Res. 2001, 61:7369-7374.
7. Harper J.W., Elledge S.J. The DNA damage response: ten years after. Mol. Cell 2007, 28:739-745.
8. Hickman M.J., Samson L.D. Apoptotic signaling in response to a single type of DNA lesion, O(6)-methylguanine. Mol. Cell 2004, 14:105-116.
9. Ho W.C., Dickson K.M., Barker P.A. Nuclear factor-kappaB induced by doxorubicin is deficient in phosphorylation and acetylation and represses nuclear factor-kappaB-dependent transcription in cancer cells. Cancer Res. 2005, 65:4273-4281.
10. Hoffmann A., Leung T.H., Baltimore D. Genetic analysis of NF-kappaB/Rel transcription factors defines functional specificities. EMBO J. 2003, 22:5530-5539.
11. Hou S., Guan H., Ricciardi R.P. Phosphorylation of serine 337 of NF-kappaB p50 is critical for DNA binding. J. Biol. Chem. 2003, 278:45994-45998.
12. Hutchins J.R., Hughes M., Clarke P.R. Substrate specificity determinants of the checkpoint protein kinase Chk1. FEBS Lett. 2000, 466:91-95.
13. Kaina B., Christmann M., Naumann S., Roos W.P. MGMT: key node in the battle against genotoxicity, carcinogenicity and apoptosis induced by alkylating agents. DNA Repair (Amst.) 2007, 6:1079-1099.
14. Karban A.S., Okazaki T., Panhuysen C.I., Gallegos T., Potter J.J., Bailey-Wilson J.E., Silverberg M.S., Duerr R.H., Cho J.H., Gregersen P.K., et al. Functional annotation of a novel NFKB1 promoter polymorphism that increases risk for ulcerative colitis. Hum. Mol. Genet. 2004, 13:35-45.
15. Karran P., Macpherson P., Ceccotti S., Dogliotti E., Griffin S., Bignami M. O6-methylguanine residues elicit DNA repair synthesis by human cell extracts. J. Biol. Chem. 1993, 268:15878-15886.
16. Krokan H., Bjorklid E., Prydz H. DNA synthesis in isolated HeLa cell nuclei. Optimalization of the system and characterization of the product. Biochemistry 1975, 14:4227-4232.
17. Li L.S., Morales J.C., Hwang A., Wagner M.W., Boothman D.A. DNA mismatch repair-dependent activation of c-Abl/p73alpha/GADD45alpha-mediated apoptosis. J. Biol. Chem. 2008, 283:21394-21403.
18. Mojas N., Lopes M., Jiricny J. Mismatch repair-dependent processing of methylation damage gives rise to persistent single-stranded gaps in newly replicated DNA. Genes Dev. 2007, 21:3342-3355.
19. Nghiem P., Park P.K., Kim Ys Y.S., Desai B.N., Schreiber S.L. ATR is not required for p53 activation but synergizes with p53 in the replication checkpoint. J. Biol. Chem. 2002, 277:4428-4434.
20. Perkins N.D. Post-translational modifications regulating the activity and function of the nuclear factor kappa B pathway. Oncogene 2006, 25:6717-6730.
21. Stojic L., Mojas N., Cejka P., Di Pietro M., Ferrari S., Marra G., Jiricny J. Mismatch repair-dependent G2 checkpoint induced by low doses of SN1 type methylating agents requires the ATR kinase. Genes Dev. 2004, 18:1331-1344.
22. Swann P.F., Waters T.R., Moulton D.C., Xu Y.Z., Zheng Q., Edwards M., Mace R. Role of postreplicative DNA mismatch repair in the cytotoxic action of thioguanine. Science 1996, 273:1109-1111.
23. Vallabhapurapu S., Karin M. Regulation and function of NF-kappaB transcription factors in the immune system. Annu. Rev. Immunol. 2009, 27:693-733.
24. Wu Z.H., Miyamoto S. Many faces of NF-kappaB signaling induced by genotoxic stress. J. Mol. Med. 2007, 85:1187-1202.
25. Wu Z.H., Miyamoto S. Induction of a pro-apoptotic ATM-NF-kappaB pathway and its repression by ATR in response to replication stress. EMBO J. 2008, 27:1963-1973.
26. Yamini B., Yu X., Dolan M.E., Wu M.H., Darga T.E., Kufe D.W., Weichselbaum R.R. Inhibition of nuclear factor-kappaB activity by temozolomide involves O6-methylguanine induced inhibition of p65 DNA binding. Cancer Res. 2007, 67:6889-6898.
27. Yang G., Scherer S.J., Shell S.S., Yang K., Kim M., Lipkin M., Kucherlapati R., Kolodner R.D., Edelmann W. Dominant effects of an Msh6 missense mutation on DNA repair and cancer susceptibility. Cancer Cell 2004, 6:139-150.
28. Yoshioka K., Yoshioka Y., Hsieh P. ATR kinase activation mediated by MutSalpha and MutLalpha in response to cytotoxic O6-methylguanine adducts. Mol. Cell 2006, 22:501-510.